Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.

about

Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.

Item

http://www.wikidata.org/entity/Q52723099

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Functional precision medicine ...... tions in head and neck cancer.

@en

Functional precision medicine ...... tions in head and neck cancer.

@nl

type

Item

label

Functional precision medicine ...... tions in head and neck cancer.

@en

Functional precision medicine ...... tions in head and neck cancer.

@nl

prefLabel

Functional precision medicine ...... tions in head and neck cancer.

@en

Functional precision medicine ...... tions in head and neck cancer.

@nl

P1476

Functional Precision Medicine ...... ptions in Head and Neck Cancer

@en

P2093

Adam A Margolin

http://www.w3.org/2001/XMLSchema#string

Carla Grandori

http://www.w3.org/2001/XMLSchema#string

Carlos L Green

http://www.w3.org/2001/XMLSchema#string

Chang Xu

http://www.w3.org/2001/XMLSchema#string

Christopher J Kemp

http://www.w3.org/2001/XMLSchema#string

Eduardo Méndez

http://www.w3.org/2001/XMLSchema#string

Franz X Schaub

http://www.w3.org/2001/XMLSchema#string

Hallie A Swan

http://www.w3.org/2001/XMLSchema#string

In S Jang

http://www.w3.org/2001/XMLSchema#string

Justin Guinney

http://www.w3.org/2001/XMLSchema#string

P2860

Gene ontology: tool for the unification of biology

Data, information, knowledge and principle: back to metabolism in KEGG

A scaling normalization method for differential expression analysis of RNA-seq data

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

Statistical methods for analysis of high-throughput RNA interference screens

Synthetic lethal screens as a means to understand and treat MYC-driven cancers

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Cancer statistics, 2016

P304

2828-2843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-17-1339

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heuijoon Park

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29599409

http://www.w3.org/2001/XMLSchema#string

P932

6004257

http://www.w3.org/2001/XMLSchema#string